Blockade of VEGFR-1 and VEGFR-2 enhances paclitaxel sensitivity in gastric cancer cells. [electronic resource]
Producer: 20140106Description: 374-80 p. digitalISSN:- 1976-2437
- Angiogenesis Inhibitors -- pharmacology
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antineoplastic Agents, Phytogenic -- pharmacology
- Bevacizumab
- Cell Hypoxia
- Cell Line, Tumor
- Drug Resistance, Neoplasm
- Gene Expression Regulation, Neoplastic -- drug effects
- Gene Knockdown Techniques
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit -- metabolism
- Paclitaxel -- pharmacology
- Placenta Growth Factor
- Pregnancy Proteins -- pharmacology
- Stomach Neoplasms -- drug therapy
- Tubulin -- genetics
- Vascular Endothelial Growth Factor Receptor-1 -- antagonists & inhibitors
- Vascular Endothelial Growth Factor Receptor-2 -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.